Six Years Since Selinexor Approval for Relapsed Multiple Myeloma: What Have We Learned? - PubMed
5 hours ago
- #Multiple Myeloma
- #Treatment Approval
- #Selinexor
- Selinexor was approved for relapsed multiple myeloma six years ago, marking a milestone in treatment.
- The article reflects on the progress and lessons learned since its approval in the management of relapsed disease.
- It highlights key clinical insights and outcomes derived from selinexor's use over the years.